INTERNATIONAL HEALTH CARE BUSINESS STRATEGIES  
  April, 2007       For Global Health Resources Subscribers & Friends of World Congress       Volume 8 Issue 1
International Healthcare Business Strategies
  In this Issue:  
 purple2.gif (818 bytes) Quote of the Month
Ray Hession, Chair, Ontario Health Quality Council, Canada
 purple2.gif (818 bytes) Sponsor Message  
  The 2007 Public Health Congress  
 purple2.gif (818 bytes) World Health Care Blog
John de Zulueta on the balance of public & private provision, by Lloyd Davis
 purple2.gif (818 bytes) Focus On...  
  Chronic Disease Management in Ireland  
 purple2.gif (818 bytes) International Executive Profile
Dr. Tomás Julínek, Minister of Health, Czech Republic
 purple2.gif (818 bytes) Subscriber Web Site  
  Links to the subscriber site  
   

"Chronic disease in Ontario is the budget-eating disease confronting the health system. This is an inconvenient truth." Ray Hession, Chair, Ontario Health Quality Council, Canada

 
 
The 2007 Public Health Congress
July 16-18, 2007 | Mandarin Oriental | Washington DC

Co-sponsored by World Congress and The Wall Street Journal, The Public Health Congress brings federal, state, and local health officials, hospital system administrators, and private sector executives together in an exclusive networking environment designed to promote collaboration and partnerships to improve preparedness, prevention, and infectious disease control.

Sign up: www.publichealthcongress.com
    

 
   World Health Care Blog
A selected entry from the World Health Care Blog, a hosted conversation on the business and practice of healthcare. Go to: http://www.worldhealthcareblog.org to check out the entire blog.

John de Zulueta on the balance of public & private provision
by Lloyd Davis
March 28, 2007 at 5:16 pm · Filed under speakers
 
John is Chairman, Sanitas, the Spanish arm of the BUPA Group, Britain's largest private healthcare provider.
Theme: Balancing State and Private Contributions in European Healthcare Systems
  
I’ve been in the health business for 16 years - this is my penance for selling fast food snacks and soft drinks earlier in my career :)

If you look at an ideal health system, you want low cost, high quality and easy access and if you can do all three you’re doing well. Spain is good at cost and quality but access isn’t easy, they have crowding and waiting lists.

When Spain reached a population of 40m all predictions were that it would reduce, but now thanks to immigration, particularly in the last five years it’s gone up to 44m. We have universal coverage for people who live here, provided by 17 autonomous regions. Catalonia, where we are today was one of the earliest and so one of the most developed but still services are characterised by budget deficits and patient dissatisfaction.

We offer complementary services - eg adult dental care or IVF where the public services can’t or won’t provide but we also play a substitute roles where public services are farming out their services to private providers. In Spain we have the equivalent of PFI (Private Finance Initiative) both in terms of construction of a hospital, or as in the Valencia model the private provision of the core clinical practice. 7 new hospitals are being built this way in Madrid and others in the Balearics. Valencia is doing PPP in 5 hospitals and 1 such hospital is coming in Madrid.

Our investment so far is 144m euros and we expect an 80m euro per year turnover or 1,200m over 15 years. The challenge for us is that we are responsible for *all* the medical care.

We have opportunities in long term care too. In long term care, public and private have been working together since the start. Most nursing homes are privately owned and managed with a 60:40 ratio of private to public funding, although public funding is set to increase soon.

There’s a range of ways to cooperate with the public system.

Direct management of publicly owned care homes.
Private ownership, private management, public offer
An allocation of a quota of publicly funded beds within a private home
PFI project to build and manage for the provincial government.

I believe there’s quite a potential for us to work as partners with the public system. Because we can do things cheaper, because we control our costs and are willing to work with a capitative price. There's been more interest in conservative-controlled areas, but it’s increasing in all the regions because the advantages are so clear.

Q: I’ve had responsibility for PPP and one difficult thing is service levels - who sets the clinical criteria by which you decide, say, how many transplants get done (or not)?
A: We haven’t really started on that battle yet as we’re just starting building. But it’s a joint decision. In the ones that are operating there is a dialogue - if we don’t have capacity then sometimes it will be picked up by public but occasionally, we will lose money and then we cry :(

Q: How does a public system deal with profits or gains in productivity.
A: Profits are capped, so gains in productivity are immediate for the public purse. They allow us a certain margin but above that it goes back to them.

Q: Why was it necessary for this mix of public and private? (Why not just private?)
A: It’s a political objection, since it’s based on universal coverage and politicians are very unwilling to give the whole pie away because privatising the public system is a vote-loser.

 

   Focus on ....
Chronic Disease Management in Ireland

During the 3rd Annual World Health Care Congress Europe 2007, Dr. Orlaith O Reilly M.B., M.P.H., F.F.P.H.M.I. presented on Developing a Patient--centered Chronic Disease Management Model in a European Setting ––The Irish Experience

Dr. O Reilly noted the Importance of Chronic Disease in Ireland:

  • Chronic Disease = 60% of deaths
  • 60% of Hospital Bed Days
  • 80% of G.P. Consultations
  • 10% of Patients account for 48% of Bed Days

A National Research and Development Project was undertaken in May 2006 with the goal of recommending a National Chronic Disease Management Patient Support Programme suitable for implementation in Ireland The project recommendations were released in December 2006, and included:

  • Establishing a 3 year pilot programme of 20,000 patients
  • Diseases selected; CHD, CHF, Diabetes, Diseases selected; CHD, CHF, Diabetes, COPD and Asthma
  • External evaluations
  • Expert Provider to be contracted by EU tender
  • Telephonic nurse delivered service

The current status:

  • Tenders advertised
  • Company selection May 2007
  • Service to be commenced by October 2007
 International Executive Profile
Dr. Tomás Julínek
Minister of Health
Czech Republic
Dr Tomás Julínek was appointed Minister of Health of the Czech Republic in September 2006. In 1998 he was elected senator to represent the Brno-Rural constituency, and in 2004 served as Chairman of the Civic Democratic Party Caucus, having chaired committees on Health and Social Policy and Mandate and Parliamentary Privilege. From 1991 to the present he has served as Chief Physician in Anesthesiology and Resuscitation at Ivanãice Hospital, which he also directed from 1994-98. He has served on the faculty of Medicine at Masaryk University in Brno, and has an MBA from Brno International Business School and The Nottingham Trent University.

A searchable directory of International Healthcare Executive profiles is available in the Global Health Resources Subscriber web site.

 Global Health Resources Subscriber Web Site

Your username and password are required to access the Subscriber web site. 

 International Health Care Business Strategies is published  by MCOL in partnership with the World Congress.
 Copyright 2007, MCOL, Inc. All Rights Reserved. Use is restricted for MCOL Members only. No redistribution allowed.
To unsubscribe, please send an email to pattyj@mcol.com
Global Health Resources
1101 Standiford Ave., Suite C-3
Modesto, CA  95350
www.globalhealthresources.com